Literature DB >> 30742485

Blackboard to Bedside: A Mathematical Modeling Bottom-Up Approach Toward Personalized Cancer Treatments.

Sara Hamis1, Gibin G Powathil1, Mark A J Chaplain2.   

Abstract

Cancers present with high variability across patients and tumors; thus, cancer care, in terms of disease prevention, detection, and control, can highly benefit from a personalized approach. For a comprehensive personalized oncology practice, this personalization should ideally consider data gathered from various information levels, which range from the macroscale population level down to the microscale tumor level, without omission of the central patient level. Appropriate data mined from each of these levels can significantly contribute in devising personalized treatment plans tailored to the individual patient and tumor. Mathematical models of solid tumors, combined with patient-specific tumor profiles, present a unique opportunity to personalize cancer treatments after detection using a bottom-up approach. Here, we discuss how information harvested from mathematical models and from corresponding in silico experiments can be implemented in preclinical and clinical applications. To conceptually illustrate the power of these models, one such model is presented, and various pertinent tumor and treatment scenarios are demonstrated in silico. The presented model, specifically a multiscale, hybrid cellular automaton, has been fully validated in vitro using multiple cell-line-specific data. We discuss various insights provided by this model and other models like it and their role in designing predictive tools that are both patient, and tumor specific. After refinement and parametrization with appropriate data, such in silico tools have the potential to be used in a clinical setting to aid in treatment protocols and decision making.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30742485     DOI: 10.1200/CCI.18.00068

Source DB:  PubMed          Journal:  JCO Clin Cancer Inform        ISSN: 2473-4276


  7 in total

1.  Introduction to Mathematical Oncology.

Authors:  Russell C Rockne; Jacob G Scott
Journal:  JCO Clin Cancer Inform       Date:  2019-04

Review 2.  Integrating mechanism-based modeling with biomedical imaging to build practical digital twins for clinical oncology.

Authors:  Chengyue Wu; Guillermo Lorenzo; David A Hormuth; Ernesto A B F Lima; Kalina P Slavkova; Julie C DiCarlo; John Virostko; Caleb M Phillips; Debra Patt; Caroline Chung; Thomas E Yankeelov
Journal:  Biophys Rev (Melville)       Date:  2022-05-17

3.  Interrogating and Quantifying In Vitro Cancer Drug Pharmacodynamics via Agent-Based and Bayesian Monte Carlo Modelling.

Authors:  Marios Demetriades; Marko Zivanovic; Myrianthi Hadjicharalambous; Eleftherios Ioannou; Biljana Ljujic; Ksenija Vucicevic; Zeljko Ivosevic; Aleksandar Dagovic; Nevena Milivojevic; Odysseas Kokkinos; Roman Bauer; Vasileios Vavourakis
Journal:  Pharmaceutics       Date:  2022-03-30       Impact factor: 6.525

4.  The Goldilocks Window of Personalized Chemotherapy: Getting the Immune Response Just Right.

Authors:  Derek S Park; Mark Robertson-Tessi; Kimberly A Luddy; Philip K Maini; Michael B Bonsall; Robert A Gatenby; Alexander R A Anderson
Journal:  Cancer Res       Date:  2019-08-06       Impact factor: 12.701

Review 5.  Anakoinosis: Correcting Aberrant Homeostasis of Cancer Tissue-Going Beyond Apoptosis Induction.

Authors:  Daniel Heudobler; Florian Lüke; Martin Vogelhuber; Sebastian Klobuch; Tobias Pukrop; Wolfgang Herr; Christopher Gerner; Pan Pantziarka; Lina Ghibelli; Albrecht Reichle
Journal:  Front Oncol       Date:  2019-12-20       Impact factor: 6.244

6.  Targeting Cellular DNA Damage Responses in Cancer: An In Vitro-Calibrated Agent-Based Model Simulating Monolayer and Spheroid Treatment Responses to ATR-Inhibiting Drugs.

Authors:  Sara Hamis; James Yates; Mark A J Chaplain; Gibin G Powathil
Journal:  Bull Math Biol       Date:  2021-08-30       Impact factor: 1.758

7.  Optimal regulation of tumour-associated neutrophils in cancer progression.

Authors:  Aurelio A de Los Reyes; Yangjin Kim
Journal:  R Soc Open Sci       Date:  2022-02-02       Impact factor: 2.963

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.